Omeprazole 40 MG
Sponsors
GlaxoSmithKline, Bausch & Lomb Incorporated, Damascus Hospital, Lexicon Pharmaceuticals, Maria Sklodowska-Curie National Research Institute of Oncology
Conditions
Barretts Esophagus With Low Grade DysplasiaCoughCrohn's DiseaseDrug InteractionsDrug-drug InteractionDyspepsiaDysphoniaGastroduodenal Ulcer
Early Phase 1
Phase 1
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
CompletedNCT01489943
Start: 2011-09-19End: 2011-11-10Updated: 2017-07-25
A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
CompletedNCT03302845
Start: 2017-09-21End: 2017-11-07Updated: 2018-04-25
Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults
CompletedNCT04425902
Start: 2020-12-16End: 2021-03-10Updated: 2024-01-05
Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions
CompletedNCT05433896
Start: 2020-11-01End: 2020-12-19Updated: 2022-06-27
Phase 2
Phase 4
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
CompletedNCT02394340
Start: 2015-02-03End: 2015-04-01Updated: 2019-11-27
The Mechanism Versus PPI Trial
RecruitingNCT06999577
Start: 2025-06-04End: 2029-07-01Target: 160Updated: 2025-08-01
Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection
Not yet recruitingNCT07040839
Start: 2025-07-31End: 2026-02-28Target: 128Updated: 2025-06-27